VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q38802115  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241120235859.0
008     241120nneanz||abbn n and d
035 ‎‡a  (WKP)Q38802115‏
024 ‎‡a  0000-0002-8139-4595‏ ‎‡2  orcid‏
024 ‎‡a  36130557500‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q38802115‏
100 0 ‎‡a  António Sebastião Rodrigues‏ ‎‡c  researcher‏ ‎‡9  en‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  António Sebastião Rodrigues‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
400 0 ‎‡a  António Sebastião Rodrigues‏ ‎‡c  ricercatore‏ ‎‡9  it‏
400 0 ‎‡a  António Sebastião Rodrigues‏ ‎‡c  investigador‏ ‎‡9  es‏
400 0 ‎‡a  António Sebastião Rodrigues‏ ‎‡c  investigador‏ ‎‡9  ast‏
670 ‎‡a  Author's (99m)Tc-tricarbonyl complexes functionalized with anthracenyl fragments: synthesis, characterization, and evaluation of their radiotoxic effects in murine melanoma cells‏
670 ‎‡a  Author's ABC Efflux Transporters and the Circuitry of miRNAs: Kinetics of Expression in Cancer Drug Resistance‏
670 ‎‡a  Author's Activation of promutagens by porphyrinic biomimetic systems‏
670 ‎‡a  Author's Alkylating potential of oxetanes.‏
670 ‎‡a  Author's Brassica oleracea L. Var. costata DC and Pieris brassicae L. aqueous extracts reduce methyl methanesulfonate-induced DNA damage in V79 hamster lung fibroblasts.‏
670 ‎‡a  Author's Cancer Drug Resistance: A Brief Overview from a Genetic Viewpoint‏
670 ‎‡a  Author's Characterization of the antiproliferative potential and biological targets of a trans ketoimine platinum complex‏
670 ‎‡a  Author's Chemical features of flavonols affecting their genotoxicity. Potential implications in their use as therapeutical agents.‏
670 ‎‡a  Author's Chitosan mouthwash: toxicity and in vivo validation‏
670 ‎‡a  Author's Development and validation of alternative metabolic systems for mutagenicity testing in short-term assays‏
670 ‎‡a  Author's Development of imatinib and dasatinib resistance: dynamics of expression of drug transportersABCB1, ABCC1, ABCG2, MVP, and SLC22A1‏
670 ‎‡a  Author's DNA damage response in imatinib resistant chronic myeloid leukemia K562 cells‏
670 ‎‡a  Author's DNA-PK inhibitor wortmannin enhances DNA damage induced by bleomycin in V79 Chinese hamster cells‏
670 ‎‡a  Author's Down syndrome and microRNAs‏
670 ‎‡a  Author's Dynamics of Expression of Drug Transporters: Methods for Appraisal‏
670 ‎‡a  Author's Effect of poly(ADP-ribosyl)ation inhibitors on the genotoxic effects of the boron neutron capture reaction‏
670 ‎‡a  Author's Elevated levels of DNA-protein crosslinks and micronuclei in peripheral lymphocytes of tannery workers exposed to trivalent chromium.‏
670 ‎‡a  Author's Estragole: a weak direct-acting food-borne genotoxin and potential carcinogen.‏
670 ‎‡a  Author's Fluorimetric Methods for Analysis of Permeability, Drug Transport Kinetics, and Inhibition of the ABCB1 Membrane Transporter‏
670 ‎‡a  Author's Genetic Susceptibility in Acute Pancreatitis: Genotyping of GSTM1, GSTT1, GSTP1, CASP7, CASP8, CASP9, CASP10, LTA, TNFRSF1B, and TP53 Gene Variants‏
670 ‎‡a  Author's Genomics and cancer drug resistance.‏
670 ‎‡a  Author's Genotoxic alkenylbenzene flavourings, a contribution to risk assessment‏
670 ‎‡a  Author's Genotoxic and apoptotic activities of the food flavourings myristicin and eugenol in AA8 and XRCC1 deficient EM9 cells.‏
670 ‎‡a  Author's Genotoxicity and endoreduplication inducing activity of the food flavouring eugenol.‏
670 ‎‡a  Author's Genotoxicity assessment of aromatic amines and amides in genetically engineered V79 cells.‏
670 ‎‡a  Author's Human exposure to indoor radon: a survey in the region of Guarda, Portugal‏
670 ‎‡a  Author's In vitro and in vivo biological characterization of the anti-proliferative potential of a cyclic trinuclear organotin(iv) complex‏
670 ‎‡a  Author's Integration of HIV in the Human Genome: Which Sites Are Preferential? A Genetic and Statistical Assessment.‏
670 ‎‡a  Author's Involvement of rat cytochrome 1A1 in the biotransformation of kaempferol to quercetin: relevance to the genotoxicity of kaempferol‏
670 ‎‡a  Author's Lipoperoxidation products and thiol antioxidants in chromium exposed workers.‏
670 ‎‡a  Author's Mechanisms of myricetin mutagenicity in V79 cells: involvement of radicalar species‏
670 ‎‡a  Author's Methods for Studying MicroRNA Expression and Their Targets in Formalin-Fixed, Paraffin-Embedded (FFPE) Breast Cancer Tissues.‏
670 ‎‡a  Author's MicroRNAs and Cancer Drug Resistance‏
670 ‎‡a  Author's Myristicin from nutmeg induces apoptosis via the mitochondrial pathway and down regulates genes of the DNA damage response pathways in human leukaemia K562 cells.‏
670 ‎‡a  Author's New endoperoxides highly active in vivo and in vitro against artemisinin-resistant Plasmodium falciparum.‏
670 ‎‡a  Author's No evidence of increased chromosomal aberrations and micronuclei in lymphocytes from nonfamilial thyroid cancer patients prior to radiotherapy‏
670 ‎‡a  Author's Oxygen species and the genotoxicity of quercetin‏
670 ‎‡a  Author's Possible transient adaptive response to mitomycin C in peripheral lymphocytes from thyroid cancer patients after iodine-131 therapy‏
670 ‎‡a  Author's Prognostic value of microRNA-203a expression in breast cancer.‏
670 ‎‡a  Author's Synthesis, characterization and cytotoxic activity of gallium(III) complexes anchored by tridentate pyrazole-based ligands‏
670 ‎‡a  Author's The drug transporter ABCB1 c.3435C>T SNP influences artemether-lumefantrine treatment outcome‏
670 ‎‡a  Author's Use of cytogenetic indicators in radiobiology.‏
670 ‎‡a  Author's Wortmannin enhances the induction of micronuclei by low and high LET radiation.‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/ISNI|0000000067994477‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/viaf/99389706‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/LC|nb2016006991‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/SUDOC|192380206‏
909 ‎‡a  (orcid) 0000000281394595‏ ‎‡9  1‏
909 ‎‡a  (scopus) 36130557500‏ ‎‡9  1‏
919 ‎‡a  abceffluxtransportersandthecircuitryofmirnaskineticsofexpressionincancerdrugresistance‏ ‎‡A  ABC Efflux Transporters and the Circuitry of miRNAs: Kinetics of Expression in Cancer Drug Resistance‏ ‎‡9  1‏
919 ‎‡a  alkylatingpotentialofoxetanes‏ ‎‡A  Alkylating potential of oxetanes.‏ ‎‡9  1‏
919 ‎‡a  brassicaoleracea50varcostata600andpierisbrassicae50aqueousextractsreducemethylmethanesulfonateinduceddnadamageinv79hamsterlungfibroblasts‏ ‎‡A  Brassica oleracea L. Var. costata DC and Pieris brassicae L. aqueous extracts reduce methyl methanesulfonate-induced DNA damage in V79 hamster lung fibroblasts.‏ ‎‡9  1‏
919 ‎‡a  cancerdrugresistanceabriefoverviewfromageneticviewpoint‏ ‎‡A  Cancer Drug Resistance: A Brief Overview from a Genetic Viewpoint‏ ‎‡9  1‏
919 ‎‡a  characterizationoftheantiproliferativepotentialandbiologicaltargetsofatransketoimineplatinumcomplex‏ ‎‡A  Characterization of the antiproliferative potential and biological targets of a trans ketoimine platinum complex‏ ‎‡9  1‏
919 ‎‡a  chemicalfeaturesofflavonolsaffectingtheirgenotoxicitypotentialimplicationsintheiruseastherapeuticalagents‏ ‎‡A  Chemical features of flavonols affecting their genotoxicity. Potential implications in their use as therapeutical agents.‏ ‎‡9  1‏
919 ‎‡a  chitosanmouthwashtoxicityandinvivovalidation‏ ‎‡A  Chitosan mouthwash: toxicity and in vivo validation‏ ‎‡9  1‏
919 ‎‡a  developmentandvalidationofalternativemetabolicsystemsformutagenicitytestinginshorttermassays‏ ‎‡A  Development and validation of alternative metabolic systems for mutagenicity testing in short-term assays‏ ‎‡9  1‏
919 ‎‡a  developmentofimatinibanddasatinibresistancedynamicsofexpressionofdrugtransportersabcb1abcc1abcg2mvpandslc22a1‏ ‎‡A  Development of imatinib and dasatinib resistance: dynamics of expression of drug transportersABCB1, ABCC1, ABCG2, MVP, and SLC22A1‏ ‎‡9  1‏
919 ‎‡a  dnadamageresponseinimatinibresistantchronicmyeloidleukemiak562cells‏ ‎‡A  DNA damage response in imatinib resistant chronic myeloid leukemia K562 cells‏ ‎‡9  1‏
919 ‎‡a  dnapkinhibitorwortmanninenhancesdnadamageinducedbybleomycininv79chinesehamstercells‏ ‎‡A  DNA-PK inhibitor wortmannin enhances DNA damage induced by bleomycin in V79 Chinese hamster cells‏ ‎‡9  1‏
919 ‎‡a  downsyndromeandmicrornas‏ ‎‡A  Down syndrome and microRNAs‏ ‎‡9  1‏
919 ‎‡a  dynamicsofexpressionofdrugtransportersmethodsforappraisal‏ ‎‡A  Dynamics of Expression of Drug Transporters: Methods for Appraisal‏ ‎‡9  1‏
919 ‎‡a  effectofpolyadpribosylationinhibitorsonthegenotoxiceffectsoftheboronneutroncapturereaction‏ ‎‡A  Effect of poly(ADP-ribosyl)ation inhibitors on the genotoxic effects of the boron neutron capture reaction‏ ‎‡9  1‏
919 ‎‡a  elevatedlevelsofdnaproteincrosslinksandmicronucleiinperipherallymphocytesoftanneryworkersexposedtotrivalentchromium‏ ‎‡A  Elevated levels of DNA-protein crosslinks and micronuclei in peripheral lymphocytes of tannery workers exposed to trivalent chromium.‏ ‎‡9  1‏
919 ‎‡a  estragoleaweakdirectactingfoodbornegenotoxinandpotentialcarcinogen‏ ‎‡A  Estragole: a weak direct-acting food-borne genotoxin and potential carcinogen.‏ ‎‡9  1‏
919 ‎‡a  fluorimetricmethodsforanalysisofpermeabilitydrugtransportkineticsandinhibitionoftheabcb1membranetransporter‏ ‎‡A  Fluorimetric Methods for Analysis of Permeability, Drug Transport Kinetics, and Inhibition of the ABCB1 Membrane Transporter‏ ‎‡9  1‏
919 ‎‡a  geneticsusceptibilityinacutepancreatitisgenotypingofgstm1gstt1gstp1casp7casp8casp9casp10ltatnfrsf1bandtp53genevariants‏ ‎‡A  Genetic Susceptibility in Acute Pancreatitis: Genotyping of GSTM1, GSTT1, GSTP1, CASP7, CASP8, CASP9, CASP10, LTA, TNFRSF1B, and TP53 Gene Variants‏ ‎‡9  1‏
919 ‎‡a  genomicsandcancerdrugresistance‏ ‎‡A  Genomics and cancer drug resistance.‏ ‎‡9  1‏
919 ‎‡a  genotoxicalkenylbenzeneflavouringsacontributiontoriskassessment‏ ‎‡A  Genotoxic alkenylbenzene flavourings, a contribution to risk assessment‏ ‎‡9  1‏
919 ‎‡a  genotoxicandapoptoticactivitiesofthefoodflavouringsmyristicinandeugenolinaa8andxrcc1deficientem9cells‏ ‎‡A  Genotoxic and apoptotic activities of the food flavourings myristicin and eugenol in AA8 and XRCC1 deficient EM9 cells.‏ ‎‡9  1‏
919 ‎‡a  genotoxicityandendoreduplicationinducingactivityofthefoodflavouringeugenol‏ ‎‡A  Genotoxicity and endoreduplication inducing activity of the food flavouring eugenol.‏ ‎‡9  1‏
919 ‎‡a  genotoxicityassessmentofaromaticaminesandamidesingeneticallyengineeredv79cells‏ ‎‡A  Genotoxicity assessment of aromatic amines and amides in genetically engineered V79 cells.‏ ‎‡9  1‏
919 ‎‡a  humanexposuretoindoorradonasurveyintheregionofguardaportugal‏ ‎‡A  Human exposure to indoor radon: a survey in the region of Guarda, Portugal‏ ‎‡9  1‏
919 ‎‡a  invitroandinvivobiologicalcharacterizationoftheantiproliferativepotentialofacyclictrinuclearorganotin4complex‏ ‎‡A  In vitro and in vivo biological characterization of the anti-proliferative potential of a cyclic trinuclear organotin(iv) complex‏ ‎‡9  1‏
919 ‎‡a  integrationofhivinthehumangenomewhichsitesarepreferentialageneticandstatisticalassessment‏ ‎‡A  Integration of HIV in the Human Genome: Which Sites Are Preferential? A Genetic and Statistical Assessment.‏ ‎‡9  1‏
919 ‎‡a  involvementofratcytochrome1a1inthebiotransformationofkaempferoltoquercetinrelevancetothegenotoxicityofkaempferol‏ ‎‡A  Involvement of rat cytochrome 1A1 in the biotransformation of kaempferol to quercetin: relevance to the genotoxicity of kaempferol‏ ‎‡9  1‏
919 ‎‡a  lipoperoxidationproductsandthiolantioxidantsinchromiumexposedworkers‏ ‎‡A  Lipoperoxidation products and thiol antioxidants in chromium exposed workers.‏ ‎‡9  1‏
919 ‎‡a  mechanismsofmyricetinmutagenicityinv79cellsinvolvementofradicalarspecies‏ ‎‡A  Mechanisms of myricetin mutagenicity in V79 cells: involvement of radicalar species‏ ‎‡9  1‏
919 ‎‡a  methodsforstudyingmicrornaexpressionandtheirtargetsinformalinfixedparaffinembeddedffpebreastcancertissues‏ ‎‡A  Methods for Studying MicroRNA Expression and Their Targets in Formalin-Fixed, Paraffin-Embedded (FFPE) Breast Cancer Tissues.‏ ‎‡9  1‏
919 ‎‡a  micrornasandcancerdrugresistance‏ ‎‡A  MicroRNAs and Cancer Drug Resistance‏ ‎‡9  1‏
919 ‎‡a  myristicinfromnutmeginducesapoptosisviathemitochondrialpathwayanddownregulatesgenesofthednadamageresponsepathwaysinhumanleukaemiak562cells‏ ‎‡A  Myristicin from nutmeg induces apoptosis via the mitochondrial pathway and down regulates genes of the DNA damage response pathways in human leukaemia K562 cells.‏ ‎‡9  1‏
919 ‎‡a  newendoperoxideshighlyactiveinvivoandinvitroagainstartemisininresistantplasmodiumfalciparum‏ ‎‡A  New endoperoxides highly active in vivo and in vitro against artemisinin-resistant Plasmodium falciparum.‏ ‎‡9  1‏
919 ‎‡a  noevidenceofincreasedchromosomalaberrationsandmicronucleiinlymphocytesfromnonfamilialthyroidcancerpatientspriortoradiotherapy‏ ‎‡A  No evidence of increased chromosomal aberrations and micronuclei in lymphocytes from nonfamilial thyroid cancer patients prior to radiotherapy‏ ‎‡9  1‏
919 ‎‡a  oxygenspeciesandthegenotoxicityofquercetin‏ ‎‡A  Oxygen species and the genotoxicity of quercetin‏ ‎‡9  1‏
919 ‎‡a  possibletransientadaptiveresponsetomitomycin100inperipherallymphocytesfromthyroidcancerpatientsafteriodine131therapy‏ ‎‡A  Possible transient adaptive response to mitomycin C in peripheral lymphocytes from thyroid cancer patients after iodine-131 therapy‏ ‎‡9  1‏
919 ‎‡a  prognosticvalueofmicrorna203aexpressioninbreastcancer‏ ‎‡A  Prognostic value of microRNA-203a expression in breast cancer.‏ ‎‡9  1‏
919 ‎‡a  synthesischaracterizationandcytotoxicactivityofgallium3complexesanchoredbytridentatepyrazolebasedligands‏ ‎‡A  Synthesis, characterization and cytotoxic activity of gallium(III) complexes anchored by tridentate pyrazole-based ligands‏ ‎‡9  1‏
919 ‎‡a  drugtransporterabcb11003435ctsnpinfluencesartemetherlumefantrinetreatmentoutcome‏ ‎‡A  The drug transporter ABCB1 c.3435C>T SNP influences artemether-lumefantrine treatment outcome‏ ‎‡9  1‏
919 ‎‡a  useofcytogeneticindicatorsinradiobiology‏ ‎‡A  Use of cytogenetic indicators in radiobiology.‏ ‎‡9  1‏
919 ‎‡a  wortmanninenhancestheinductionofmicronucleibylowandhighletradiation‏ ‎‡A  Wortmannin enhances the induction of micronuclei by low and high LET radiation.‏ ‎‡9  1‏
919 ‎‡a  activationofpromutagensbyporphyrinicbiomimeticsystems‏ ‎‡A  Activation of promutagens by porphyrinic biomimetic systems‏ ‎‡9  1‏
919 ‎‡a  99mtctricarbonylcomplexesfunctionalizedwithanthracenylfragmentssynthesischaracterizationandevaluationoftheirradiotoxiceffectsinmurinemelanomacells‏ ‎‡A  (99m)Tc-tricarbonyl complexes functionalized with anthracenyl fragments: synthesis, characterization, and evaluation of their radiotoxic effects in murine melanoma cells‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  ISNI|0000000068379118‏
996 ‎‡2  ISNI|0000000069593212‏
996 ‎‡2  LC|n 99901467‏
996 ‎‡2  CAOONL|ncf10460051‏
996 ‎‡2  ISNI|0000000066611737‏
996 ‎‡2  PTBNP|353810‏
996 ‎‡2  CAOONL|ncf11948254‏
996 ‎‡2  BLBNB|000489896‏
996 ‎‡2  BLBNB|000607312‏
996 ‎‡2  PTBNP|122115‏
996 ‎‡2  LC|n 2011054166‏
996 ‎‡2  RERO|A009510741‏
996 ‎‡2  LC|n 88667885‏
996 ‎‡2  PTBNP|206346‏
996 ‎‡2  PTBNP|1229039‏
996 ‎‡2  ISNI|0000000068204908‏
996 ‎‡2  ISNI|0000000139277662‏
996 ‎‡2  LC|n 78083031‏
996 ‎‡2  PTBNP|204227‏
996 ‎‡2  PTBNP|1181841‏
996 ‎‡2  DNB|139703993‏
996 ‎‡2  PTBNP|225196‏
996 ‎‡2  RERO|A000138534‏
996 ‎‡2  PTBNP|1196067‏
996 ‎‡2  BLBNB|001451113‏
996 ‎‡2  ISNI|0000000383046583‏
996 ‎‡2  LC|n 88610449‏
996 ‎‡2  PTBNP|1410771‏
996 ‎‡2  PTBNP|1751585‏
996 ‎‡2  SUDOC|09561740X‏
996 ‎‡2  SUDOC|068927630‏
996 ‎‡2  ISNI|0000000496567772‏
996 ‎‡2  PLWABN|9810679831805606‏
996 ‎‡2  PTBNP|1479698‏
996 ‎‡2  PTBNP|121084‏
996 ‎‡2  PTBNP|69166‏
996 ‎‡2  BLBNB|001531200‏
996 ‎‡2  PTBNP|109479‏
996 ‎‡2  ISNI|0000000033874856‏
996 ‎‡2  BLBNB|000173370‏
996 ‎‡2  ISNI|0000000037156667‏
996 ‎‡2  PTBNP|1434791‏
996 ‎‡2  ISNI|0000000069688289‏
996 ‎‡2  ISNI|0000000034241399‏
996 ‎‡2  ISNI|0000000116913689‏
996 ‎‡2  BNF|17948344‏
996 ‎‡2  DNB|1051663792‏
996 ‎‡2  PTBNP|267850‏
996 ‎‡2  SUDOC|073308773‏
996 ‎‡2  LC|n 2021222621‏
996 ‎‡2  BLBNB|000342702‏
996 ‎‡2  SUDOC|23306978X‏
996 ‎‡2  ISNI|000000007031097X‏
996 ‎‡2  PTBNP|1782714‏
996 ‎‡2  PTBNP|1888658‏
996 ‎‡2  ISNI|0000000039939577‏
996 ‎‡2  PTBNP|1788598‏
996 ‎‡2  PTBNP|1807639‏
996 ‎‡2  PTBNP|1704283‏
996 ‎‡2  PTBNP|1039693‏
996 ‎‡2  PTBNP|128753‏
996 ‎‡2  ISNI|0000000028301201‏
996 ‎‡2  DNB|1020154314‏
996 ‎‡2  BLBNB|000524105‏
996 ‎‡2  DNB|1028893434‏
996 ‎‡2  ISNI|000000006969315X‏
996 ‎‡2  SUDOC|083808035‏
996 ‎‡2  LC|n 2017059613‏
996 ‎‡2  LC|n 2017059615‏
996 ‎‡2  J9U|987007295051505171‏
996 ‎‡2  PTBNP|1888157‏
996 ‎‡2  PTBNP|112190‏
996 ‎‡2  ISNI|0000000069831647‏
996 ‎‡2  PTBNP|86537‏
996 ‎‡2  SUDOC|138545162‏
996 ‎‡2  PTBNP|1212119‏
996 ‎‡2  BLBNB|000379506‏
996 ‎‡2  ISNI|0000000068417102‏
996 ‎‡2  ISNI|0000000111934261‏
996 ‎‡2  LC|n 85119852‏
996 ‎‡2  ISNI|0000000108375112‏
996 ‎‡2  ISNI|0000000069587744‏
996 ‎‡2  PTBNP|187945‏
996 ‎‡2  LC|n 2009048037‏
996 ‎‡2  LC|no2013021457‏
996 ‎‡2  ISNI|000000006921565X‏
996 ‎‡2  PTBNP|103453‏
996 ‎‡2  PTBNP|1749706‏
996 ‎‡2  ISNI|0000000395311268‏
996 ‎‡2  LC|n 2021252906‏
996 ‎‡2  PTBNP|47749‏
996 ‎‡2  DNB|1047955792‏
996 ‎‡2  SUDOC|266806937‏
996 ‎‡2  ISNI|0000000068194009‏
996 ‎‡2  BLBNB|001480566‏
996 ‎‡2  ISNI|0000000428225551‏
996 ‎‡2  ISNI|0000000428131985‏
996 ‎‡2  BNF|12635604‏
996 ‎‡2  PTBNP|181499‏
996 ‎‡2  ISNI|0000000067806827‏
996 ‎‡2  PTBNP|151745‏
996 ‎‡2  PTBNP|1268125‏
996 ‎‡2  BLBNB|000456916‏
996 ‎‡2  ISNI|0000000112919266‏
996 ‎‡2  PTBNP|1490119‏
996 ‎‡2  LC|nr 98042083‏
996 ‎‡2  BNF|17731489‏
996 ‎‡2  PTBNP|1014515‏
996 ‎‡2  RERO|A016874329‏
996 ‎‡2  ISNI|0000000067427712‏
996 ‎‡2  ISNI|0000000067823643‏
996 ‎‡2  ISNI|0000000140401640‏
996 ‎‡2  ISNI|000000038143227X‏
996 ‎‡2  DNB|1035801078‏
996 ‎‡2  BLBNB|000335463‏
996 ‎‡2  BLBNB|000335462‏
996 ‎‡2  PTBNP|1663088‏
996 ‎‡2  BLBNB|000335467‏
996 ‎‡2  BLBNB|000335469‏
996 ‎‡2  DNB|1172224153‏
996 ‎‡2  PTBNP|181642‏
996 ‎‡2  ISNI|0000000373517011‏
996 ‎‡2  BNF|14630379‏
996 ‎‡2  PTBNP|1047623‏
996 ‎‡2  ISNI|0000000067776226‏
996 ‎‡2  PTBNP|78774‏
996 ‎‡2  ISNI|0000000111967899‏
996 ‎‡2  ISNI|0000000068688105‏
996 ‎‡2  BLBNB|000534805‏
996 ‎‡2  LC|n 2016189841‏
996 ‎‡2  SUDOC|070122520‏
996 ‎‡2  LC|no 00021721‏
996 ‎‡2  NII|DA16135315‏
996 ‎‡2  LC|n 99831910‏
996 ‎‡2  LC|nb2021012912‏
996 ‎‡2  BLBNB|000477011‏
996 ‎‡2  PTBNP|973607‏
996 ‎‡2  ISNI|0000000077815276‏
996 ‎‡2  ISNI|0000000048699579‏
996 ‎‡2  PTBNP|250708‏
996 ‎‡2  ISNI|0000000078143002‏
996 ‎‡2  SUDOC|194366073‏
996 ‎‡2  PTBNP|151078‏
996 ‎‡2  BLBNB|000561654‏
996 ‎‡2  PTBNP|1535633‏
996 ‎‡2  ISNI|0000000084580540‏
996 ‎‡2  BLBNB|001594957‏
996 ‎‡2  PTBNP|1888260‏
996 ‎‡2  PTBNP|1557866‏
996 ‎‡2  LC|n 2011214560‏
996 ‎‡2  SUDOC|117995533‏
996 ‎‡2  LC|n 2006210758‏
996 ‎‡2  SUDOC|030346495‏
996 ‎‡2  PTBNP|1382876‏
996 ‎‡2  NUKAT|n 2020000958‏
996 ‎‡2  PTBNP|1340577‏
996 ‎‡2  ISNI|0000000036350476‏
996 ‎‡2  LC|n 93073992‏
996 ‎‡2  BLBNB|000162160‏
996 ‎‡2  ISNI|0000000024826406‏
996 ‎‡2  DNB|1076593941‏
996 ‎‡2  PTBNP|144305‏
996 ‎‡2  BNF|16589393‏
996 ‎‡2  BLBNB|000190465‏
996 ‎‡2  ISNI|0000000068402787‏
996 ‎‡2  PLWABN|9813267331205606‏
996 ‎‡2  BLBNB|000683779‏
996 ‎‡2  PTBNP|1552097‏
996 ‎‡2  PTBNP|183882‏
996 ‎‡2  BLBNB|000303041‏
996 ‎‡2  JPG|500061514‏
996 ‎‡2  BLBNB|000335465‏
996 ‎‡2  NTA|128226684‏
996 ‎‡2  PTBNP|1919954‏
996 ‎‡2  PTBNP|1431070‏
996 ‎‡2  BLBNB|000427439‏
996 ‎‡2  ISNI|0000000062264977‏
996 ‎‡2  ISNI|0000000037318902‏
996 ‎‡2  ISNI|0000000139453232‏
996 ‎‡2  PTBNP|1181775‏
996 ‎‡2  ISNI|000000007053034X‏
996 ‎‡2  PTBNP|1790184‏
996 ‎‡2  DNB|1158980868‏
996 ‎‡2  LC|n 83217156‏
996 ‎‡2  PTBNP|280598‏
996 ‎‡2  BLBNB|001334855‏
996 ‎‡2  DNB|1114403229‏
996 ‎‡2  BLBNB|000485251‏
996 ‎‡2  BLBNB|000458134‏
996 ‎‡2  ISNI|0000000069994526‏
996 ‎‡2  LC|no2008162170‏
996 ‎‡2  BNF|12178050‏
996 ‎‡2  LC|n 99901124‏
996 ‎‡2  ISNI|0000000066659124‏
996 ‎‡2  PTBNP|285824‏
996 ‎‡2  ISNI|0000000066544087‏
996 ‎‡2  ISNI|0000000079076673‏
996 ‎‡2  ISNI|0000000069929935‏
996 ‎‡2  SUDOC|159341124‏
996 ‎‡2  BNE|XX1092428‏
996 ‎‡2  DNB|172532450‏
996 ‎‡2  SUDOC|119664348‏
996 ‎‡2  LC|nr2001030204‏
996 ‎‡2  ISNI|000000006969331X‏
996 ‎‡2  PTBNP|246084‏
996 ‎‡2  LC|no 94024172‏
996 ‎‡2  ISNI|000000006861160X‏
996 ‎‡2  ISNI|000000005002137X‏
996 ‎‡2  J9U|987007439084605171‏
996 ‎‡2  PTBNP|253888‏
996 ‎‡2  ISNI|0000000069285359‏
996 ‎‡2  PTBNP|284662‏
996 ‎‡2  ISNI|0000000070202127‏
996 ‎‡2  PTBNP|1264559‏
996 ‎‡2  RERO|A027677441‏
996 ‎‡2  PTBNP|1323406‏
996 ‎‡2  ISNI|0000000031773381‏
996 ‎‡2  LC|no2006065222‏
996 ‎‡2  ISNI|0000000067139219‏
996 ‎‡2  PTBNP|905021‏
996 ‎‡2  PTBNP|1049965‏
996 ‎‡2  NUKAT|n 2016233187‏
996 ‎‡2  LC|n 86133125‏
996 ‎‡2  LC|n 85262805‏
996 ‎‡2  ISNI|0000000067985888‏
996 ‎‡2  LC|no2007064109‏
996 ‎‡2  ISNI|0000000068389578‏
996 ‎‡2  ISNI|0000000069079889‏
996 ‎‡2  ISNI|0000000389650474‏
996 ‎‡2  BAV|495_281482‏
996 ‎‡2  BLBNB|000567210‏
996 ‎‡2  BLBNB|000432910‏
996 ‎‡2  DNB|1279197153‏
996 ‎‡2  ISNI|0000000138914148‏
996 ‎‡2  DNB|105645380X‏
996 ‎‡2  LC|n 88193800‏
996 ‎‡2  LC|no 99087886‏
996 ‎‡2  BLBNB|000358171‏
996 ‎‡2  LC|n 2022048735‏
996 ‎‡2  LC|n 2024014011‏
996 ‎‡2  SUDOC|073767328‏
996 ‎‡2  PTBNP|109439‏
996 ‎‡2  BLBNB|000432299‏
996 ‎‡2  NII|DA04865569‏
996 ‎‡2  DNB|1074711602‏
996 ‎‡2  DNB|1136755225‏
996 ‎‡2  PLWABN|9813255103705606‏
996 ‎‡2  ISNI|0000000042025274‏
996 ‎‡2  ISNI|0000000068982013‏
996 ‎‡2  ISNI|0000000070110118‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏
998 ‎‡a  Rodrigues, Antonio Sebastião‏ ‎‡2  LC|nb2016006991‏ ‎‡3  suggested‏ ‎‡3  title: (0.82, 'cancerdrugresistance', 'genomicsandcancerdrugresistance')‏
998 ‎‡a  Rodrigues, António Sebastião‏ ‎‡2  SUDOC|192380206‏ ‎‡3  suggested‏
998 ‎‡a  Rodrigues, António Sebastião‏ ‎‡2  ISNI|0000000067994477‏ ‎‡3  suggested‏